HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prevention of congenital toxoplasmosis with spiramycin; value and limits of levels in amniotic fluid].

AuthorsP Bourget, A Lesne-Hulin, F Forestier, V Desmaris, E Dulac
JournalTherapie (Therapie) 1996 Nov-Dec Vol. 51 Issue 6 Pg. 685-7 ISSN: 0040-5957 [Print] France
Vernacular TitlePrévention de la toxoplasmose congénitale par la spiramycine; intérêt et limites du dosage dans le liquide amniotique.
PMID9164006 (Publication Type: Letter)
Chemical References
  • Anti-Bacterial Agents
  • Spiramycin
Topics
  • Adolescent
  • Adult
  • Amniotic Fluid (chemistry)
  • Anti-Bacterial Agents (therapeutic use)
  • Female
  • Humans
  • Pregnancy
  • Prospective Studies
  • Spiramycin (analysis, therapeutic use)
  • Toxoplasmosis, Congenital (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: